Arai H - Search Results

1

Effect of genetic risk factors and disease progression on the cerebrospinal fluid tau levels in Alzheimer's disease.

Arai H, Terajima M, Miura M, Higuchi S, Muramatsu T, Matsushita S, Machida N, Nakagawa T, Lee VM, Trojanowski JQ, Sasaki H. Arai H, et al. J Am Geriatr Soc. 1997 Oct;45(10):1228-31. doi: 10.1111/j.1532-5415.1997.tb03775.x. J Am Geriatr Soc. 1997. PMID: 9329486

2

No increase in cerebrospinal fluid tau protein levels in patients with vascular dementia.

Arai H, Satoh-Nakagawa T, Higuchi M, Morikawa Y, Miura M, Kawakami H, Seki H, Takase S, Sasaki H. Arai H, et al. Neurosci Lett. 1998 Nov 13;256(3):174-6. doi: 10.1016/s0304-3940(98)00781-2. Neurosci Lett. 1998. PMID: 9855368 Clinical Trial.

3

Cerebrospinal fluid tau protein levels in demented and nondemented alcoholics.

Morikawa Y, Arai H, Matsushita S, Kato M, Higuchi S, Miura M, Kawakami H, Higuchi M, Okamura N, Tashiro M, Matsui T, Sasaki H. Morikawa Y, et al. Among authors: arai h. Alcohol Clin Exp Res. 1999 Apr;23(4):575-7. Alcohol Clin Exp Res. 1999. PMID: 10235290

4

Cerebrospinal fluid amyloid beta(1-42) levels in the mild cognitive impairment stage of Alzheimer's disease.

Maruyama M, Arai H, Sugita M, Tanji H, Higuchi M, Okamura N, Matsui T, Higuchi S, Matsushita S, Yoshida H, Sasaki H. Maruyama M, et al. Among authors: arai h. Exp Neurol. 2001 Dec;172(2):433-6. doi: 10.1006/exnr.2001.7814. Exp Neurol. 2001. PMID: 11716567

5

[Tau protein in cerebrospinal fluid--a potential marker of Alzheimer's disease].

Arai H, Satoh K, Terajima M, Nakagawa T, Higuchi M, Kosaka Y, Zhu C, Sasaki H. Arai H, et al. Nihon Ronen Igakkai Zasshi. 1996 Sep;33(9):669-75. doi: 10.3143/geriatrics.33.669. Nihon Ronen Igakkai Zasshi. 1996. PMID: 8940864 Free article. Clinical Trial. Japanese.

6

Alpha 1-antichymotrypsin gene polymorphism and risk for Alzheimer's disease.

Muramatsu T, Matsushita S, Arai H, Sasaki H, Higuchi S. Muramatsu T, et al. Among authors: arai h. J Neural Transm (Vienna). 1996;103(10):1205-10. doi: 10.1007/BF01271205. J Neural Transm (Vienna). 1996. PMID: 9013407

7

Apolipoprotein E genotyping and cerebrospinal fluid tau protein: implications for the clinical diagnosis of Alzheimer's disease.

Arai H, Higuchi S, Sasaki H. Arai H, et al. Gerontology. 1997;43 Suppl 1:2-10. doi: 10.1159/000213879. Gerontology. 1997. PMID: 9187933 Review.

8

Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology.

Arai H, Morikawa Y, Higuchi M, Matsui T, Clark CM, Miura M, Machida N, Lee VM, Trojanowski JQ, Sasaki H. Arai H, et al. Biochem Biophys Res Commun. 1997 Jul 18;236(2):262-4. doi: 10.1006/bbrc.1997.6908. Biochem Biophys Res Commun. 1997. PMID: 9240421 Free article.

9

Presenilin-1 polymorphism in Alzheimer's disease and vascular dementia.

Matsushita S, Arai H, Muramatsu T, Makimoto K, Nakagawa T, Sasaki H, Higuchi S. Matsushita S, et al. Among authors: arai h. Exp Neurol. 1997 Aug;146(2):567-9. doi: 10.1006/exnr.1997.6558. Exp Neurol. 1997. PMID: 9270069

10

Regional cerebral glucose utilization is modulated by the dosage of apolipoprotein E type 4 allele and alpha1-antichymotrypsin type A allele in Alzheimer's disease.

Higuchi M, Arai H, Nakagawa T, Higuchi S, Muramatsu T, Matsushita S, Kosaka Y, Itoh M, Sasaki H. Higuchi M, et al. Among authors: arai h. Neuroreport. 1997 Aug 18;8(12):2639-43. doi: 10.1097/00001756-199708180-00001. Neuroreport. 1997. PMID: 9295092

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,760 results

Search Page

Filters